Feasibility Assessment of the Prophylactic Use of AneuFix at the Time of EVAR Implantation
This study is set up to assess the feasibility and safety of the clinical procedure using AneuFix in a prophylactic setting at the time of EVAR endograft implantation.
• Asymptomatic, infrarenal AAA that requires surgery with a high-risk profile of developing endoleak type II in line with the recommendations of Guntner et al:
• \- Open IMA AND
⁃ 1 patent lumbar AND a cross-sectional area at the location of the IMA (CSAIMA) \>17,5cm2 OR
⁃ 2 patent lumbars AND a CSAIMA \>15cm2 OR
⁃ 5 patent lumbars AND a CSAIMA \>7,5 cm2
• Infrarenal neck according to the IFU of the EVAR device
• Other aortic-iliac anatomical configuration suitable for EVAR according to the criteria of the EVAR device to be used
• Patient having a life expectation of at least 2 years
• Being older than 18 years
• Willing and able to comply with the requirements of this clinical study